Amneal Pharmaceuticals (AMRX) Selling, General & Administrative (2017 - 2026)
Amneal Pharmaceuticals' Selling, General & Administrative was $148.72 million in Q2 2026, up 19.7% from $124.27 million a year earlier and up 7.1% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Selling, General & Administrative (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Amneal Pharmaceuticals' Selling, General & Administrative was $571.86 million through Jun 30, 2026, up 16.7% year-over-year; for FY2025, it was $526.83 million, up 10.6% from FY2024.
- Selling, General & Administrative has now increased for eight consecutive years, with a five-year compound annual growth rate of 10.0% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $476.44 million in FY2024 (+10.9%), $429.68 million in FY2023 (+7.5%), $399.7 million in FY2022 (+9.4%) and $365.5 million in FY2021 (+11.9%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q2 2017.
- Compared with a year earlier, Selling, General & Administrative has increased for 25 straight quarters, with growth averaging 12.7% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 3.5% (Q1 2023) to 19.7% (Q2 2026).
- Per Business Quant data, AMRX's Selling, General & Administrative in the three quarters before Q2 2026 was $138.86 million (Q1 2026), $146.46 million (Q4 2025) and $137.82 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Amneal Pharmaceuticals | 6.41 Bn | 5.68 Bn | 334.51 Mn | 148.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 148.72 Mn |
| Mar 31, 2026 | 138.86 Mn |
| Dec 31, 2025 | 146.46 Mn |
| Sep 30, 2025 | 137.82 Mn |
| Jun 30, 2025 | 124.27 Mn |
| Mar 31, 2025 | 118.29 Mn |
| Dec 31, 2024 | 128.69 Mn |
| Sep 30, 2024 | 118.69 Mn |
| Jun 30, 2024 | 116.46 Mn |
| Mar 31, 2024 | 112.60 Mn |
| Dec 31, 2023 | 109.00 Mn |
| Sep 30, 2023 | 113.01 Mn |
| Jun 30, 2023 | 105.57 Mn |
| Mar 31, 2023 | 102.10 Mn |
| Dec 31, 2022 | 102.16 Mn |
| Sep 30, 2022 | 100.07 Mn |
| Jun 30, 2022 | 98.81 Mn |
| Mar 31, 2022 | 98.67 Mn |
| Dec 31, 2021 | 97.22 Mn |
| Sep 30, 2021 | 91.40 Mn |
API Access
Amneal Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();